ANOAT THERAPEUTICS
Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
ANOAT THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Product Research Therapeutics
Founded:
2023-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Total Employee:
1+
Status:
Active
Total Funding:
2 M EUR
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Investors List
AdBio partners
AdBio partners investment in Seed Round - Anoat Therapeutics
More informations about "Anoat Therapeutics"
Anoat Therapeutics raises €2M in seed funding to develop novel ...
About Anoat Therapeutics Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases who have …See details»
ANOAT THERAPEUTICS - Societe.com
Mar 23, 2023 ANOAT THERAPEUTICS Societé par actions simplifiée en cours de liquidation au capital de 13.986 Siège social : 4 Rue Thénard 75005 PARIS 949 945 323 R.C.S. Paris Par …See details»
€2m raised in seed funding to develop novel therapies …
Jun 19, 2023 Anoat will use the funds to conduct additional in vivo and in vitro pharmacology assessments and select a lead candidate. Anoat Therapeutics’ …See details»
Alain Huriez on LinkedIn: Newly created Anoat Tx raises €2M in …
Great news: Anoat Therapeutics raises €2M in seed funding to develop novel therapies for Cystic Fibrosis patients. The newly created biotech company is the first startup resulting from AdBio ...See details»
Anoat Therapeutics lève 2 millions d’euros en ... - Biotech.info
Jun 19, 2023 Le programme phare d’Anoat est un ASO conçu pour cibler un canal chlorure alternatif et compenser l’activité défectueuse/manquante de la protéine du canal CFTR chez …See details»
Anoat Therapeutics - PitchBook
Anoat Therapeutics General Information Description. Developer of novel therapies designed to transform the lives of patients with rare diseases. The company specializes in bringing a …See details»
Anoat Therapeutics - Funding, Financials, Valuation & Investors
Jun 19, 2023 Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Anoat raises funds to tackle cystic fibrosis - Labiotech.eu
Jun 20, 2023 Anoat Therapeutics, a French preclinical stage biotechnology company specialized in cystic fibrosis (CF), has raised €2 million ($2.17 million) in seed funding from AdBio partners. Anoat will use the funds to conduct …See details»
Anoat Therapeutics - VentureRadar
Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its …See details»
Anoat Therapeutics raises €2M in seed funding to …
Jun 19, 2023 About Anoat Therapeutics. Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. The …See details»
Anoat Therapeutics SAS - Drug pipelines, Patents, Clinical trials
Jun 1, 2024 Explore Anoat Therapeutics SAS with its drug pipeline, therapeutic area, technology platform, . Explore Anoat Therapeutics SAS with its drug pipeline, therapeutic area, technology …See details»
Paris-based Anoat Therapeutics raises €2 million Seed ... - EU …
Jun 19, 2023 Founded in 2023, Anoat Therapeutics’ goal is to bring a transformative and mutation-agnostic treatment option to CF patients for whom existing therapies are not effective …See details»
Anoat Therapeutics lève 2 millions d’euros en amorçage pour …
Jun 19, 2023 Anoat Therapeutics, société de biotechnologie au stade préclinique spécialisée dans la mucoviscidose, annonce aujourd'hui avoir levé 2 millions d'euros en amorçage auprès …See details»
Société ANOAT THERAPEUTICS : Chiffre d'affaires, statuts
ANOAT THERAPEUTICS à PARIS (75005) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS, SIREN ...See details»
Seed funding at Anoat Therapeutics to support work in cystic
Jun 20, 2023 Anoat Therapeutics has raised €2 million (US$2.17 million) in seed funding to develop novel therapies for cystic fibrosis. The financing comes from a seed funding …See details»
Paris-based Anoat Therapeutics raises €2 million Seed to develop …
Jun 19, 2023 Founded in 2023, Anoat Therapeutics’ goal is to bring a transformative and mutation-agnostic treatment option to CF patients for whom existing therapies are not effective …See details»
Anoat Therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Last update 01 Nov 2024. Anoat Therapeutics. Startups |See details»
Anoat Therapeutics Raises €2M in Seed Funding - FinSMEs
Jun 19, 2023 Anoat Therapeutics, a Paris, France-based preclinical stage biotechnology company specialized in Cystic Fibrosis (CF), raised €2M in Seed funding.. The round was led …See details»
Anoat takes aim at alternative chloride channel to treat cystic ...
Aug 10, 2023 One startup hoping to address this is Anoat Therapeutics. With more than 70,000 people living with cystic fibrosis (CF) worldwide, according to the Cystic Fibrosis Foundation, …See details»